Feb
10
2012
Enter your phone number (no dashes) and we'll call you now.
1-866-9-4EDGAR
Toll Free 24/7 (1-866-943-3427)
Pergolide and Permax Pulled from Market Legal Evaluation
Fill out this form to get a free legal evaluation. A legal expert will examine your situation to see if you have a case.
Recent News
Parkinson’s Drug Permax Pulled from Market
March 2007
The manufacturers of pergolide, sold as Permax and generic versions, have pulled the Parkinson’s drug due to significant risks of heart valve damage, and even death. The Food and Drug Administration (FDA) announced that Valeant Pharmaceuticals would voluntarily end the production and distribution of Permax. Companies Par and Teva will also cease manufacture of their generic brands.
Studies have shown that incidence of heart valve damage may occur in up to 23 percent of Permax and pergolide patients. Users of the medication should be aware that stopping use abruptly may be extremely dangerous. Instead, patients should consult their doctors to discuss alternative treatments to pergolide drugs.
Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.
Source: "FDA Announces Voluntary Withdrawal of Pergolide Products." FDA Press Release. March 29, 2007.
Source: "FDA Announces Voluntary Withdrawal of Pergolide Products." FDA Press Release. March 29, 2007.
